- Title
- Poor Survival Outcomes of Checkpoint Inhibitors for B-Cell Lymphomas Relapsing after or Refractory to CAR T-Cell Therapy: A Real-World Cohort from 15 U.S. Academic Institutions
- Creators
- Ajay Major - University of ChicagoJovian Yu - University of ChicagoNavika D. Shukla - University of ChicagoRachel Treitman - University of Colorado Cancer CenterManali K. Kamdar - University of Colorado Cancer CenterBradley M. Haverkos - University of Colorado Cancer CenterJames Godfrey - City of HopeMelissa A. Babcook - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteTimothy J. Voorhees - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteSophie G Carlson - 6UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CADaria Gaut - 6UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CACaspian Oliai - 6UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CAJason T. Romancik - Emory UniversityAllison Winter - Cleveland ClinicBrian T. Hill - Cleveland ClinicRadhika Bansal - Mayo ClinicJose C. Villasboas - 11Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MNImran A. Nizamuddin - Western UniversityReem Karmali - Northwestern UniversityLindsey A. Fitzgerald - Huntsman Cancer InstituteDeborah M. Stephens - Huntsman Cancer InstitutePriyanka A. Pophali - University of Wisconsin Carbone Cancer CenterAsaad Trabolsi - Sylvester Comprehensive Cancer CenterJonathan H. Schatz - Sylvester Comprehensive Cancer CenterMarie Hu - University of MinnesotaVeronika Bachanova - University of MinnesotaMichael J Slade - Washington University in St. LouisNathan Singh - Washington University in St. LouisNausheen Ahmed - The University of Kansas Cancer CenterJoseph P. McGuirk - University of Kansas Medical CenterMichael R. Bishop - University of ChicagoPeter A. Riedell - University of ChicagoJustin Kline - University of Chicago
- Publication Details
- Blood, Vol.140(Supplement 1), pp.1328-1331
- Publisher
- Elsevier Inc
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hospital Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031786600802976
Journal article
Poor Survival Outcomes of Checkpoint Inhibitors for B-Cell Lymphomas Relapsing after or Refractory to CAR T-Cell Therapy: A Real-World Cohort from 15 U.S. Academic Institutions
Blood, Vol.140(Supplement 1), pp.1328-1331
2022-11-15
Metrics
5 Record Views
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites